NORBIT And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – NORBIT (NORBT.OL), BOIRON (BOI.PA), SMTPC (SMTPC.PA) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. NORBIT (NORBT.OL)

33.5% sales growth and 19.45% return on equity

NORBIT ASA provides technology products and solutions. It operates through three segments: Oceans, Connectivity, and Product Innovation and Realization. The company designs and develops wideband multibeam sonars used for hydrographic and forward-looking applications, as well as for detection of advanced subsea leakage; and provides cable assemblies, electromechanical box builds, and business solutions. It also offers sensors and sensor platforms used for monitoring, detection, and reporting tasks; GuardPoint, a surveillance sonar used to detect underwater intruders; SafePoint that use to detect navigational obstacles; NORTrace, a software that simulates and graphs the underwater propagation of various sonar; SeaCOP software system for monitoring, detection, and emergency response for maritime and offshore operations; and security solutions for defense. In addition, the company provides high power underwater lights, power cabinets, and other sensor solutions for aquaculture industry. Further, it offers dedicated short-range communication (DSRC) technology for intelligent traffic systems and truck applications; global navigation satellite systems-based tolling and DSRC devices, and connectivity modules for smart tachographs; desktop readers; roadside units; and reclosable fasteners. The company was founded in 1980 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, NORBIT has a trailing twelve months EPS of kr1.34.

PE Ratio

NORBIT has a trailing twelve months price to earnings ratio of 28.21. Meaning, the purchaser of the share is investing kr28.21 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.45%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 200% and 79.5%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NORBIT’s EBITDA is 37.28.

Yearly Top and Bottom Value

NORBIT’s stock is valued at kr37.80 at 19:15 EST, under its 52-week high of kr40.00 and way higher than its 52-week low of kr22.90.

2. BOIRON (BOI.PA)

17.2% sales growth and 9.87% return on equity

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Earnings Per Share

As for profitability, BOIRON has a trailing twelve months EPS of €2.89.

PE Ratio

BOIRON has a trailing twelve months price to earnings ratio of 14.65. Meaning, the purchaser of the share is investing €14.65 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.

3. SMTPC (SMTPC.PA)

10.7% sales growth and 19.13% return on equity

Société Marseillaise du Tunnel Prado Carénage constructs and operates tunnels in France. It operates the Prado Carénage, Rège and Prado Sud, Prado South tunnels. The company was incorporated in 1989 and is headquartered in Marseille, France.

Earnings Per Share

As for profitability, SMTPC has a trailing twelve months EPS of €1.18.

PE Ratio

SMTPC has a trailing twelve months price to earnings ratio of 22.89. Meaning, the purchaser of the share is investing €22.89 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.13%.

Sales Growth

SMTPC’s sales growth is 10.7% for the ongoing quarter and 10.7% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.7%, now sitting on 35.32M for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jul 5, 2022, the estimated forward annual dividend rate is 1.9 and the estimated forward annual dividend yield is 7.01%.

Moving Average

SMTPC’s value is above its 50-day moving average of €26.99 and below its 200-day moving average of €27.81.

4. SPAREBANK 1 SMN (MING.OL)

9.7% sales growth and 11.54% return on equity

SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, green, car, boat, other vehicles, and consumer loans, as well as refinancing, as well as savings accounts. It also provides BSU house savings for young people, BSU, and mikrosparing, as well as fixed rate and green deposits, and placement accounts; savings funds; investment solutions, such as share savings accounts, stock trading, and private banking services; and individual pension savings, and pension savings accounts. In addition, the company offers vehicle, housing and travel, person, animal, and valuables insurance services; property buying and selling advisory services; and mobile and online banking, and various debit and credit cards. Further, it offers loans and finances, including bank guarantees, corporate and construction loans, operating credit for agriculture, factoring, invoice sales, leasing, and liquidity loans with government guarantees; various pension products; and business and personal insurance products. Additionally, the company provides services, including accounting and payroll, HR, taxes and duties, and change of ownership, as well as IT solutions. It offers real estate agency, advisory, and external and equity financing services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr11.43.

PE Ratio

SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 15.43. Meaning, the purchaser of the share is investing kr15.43 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

Sales Growth

SPAREBANK 1 SMN’s sales growth is negative 0.7% for the ongoing quarter and 9.7% for the next.

5. ORKLA (ORK.OL)

6.1% sales growth and 12.77% return on equity

Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery retail trade, as well as the out-of-home, convenience store, and petrol station sectors. It also provides confectionery, biscuit, and snack products; and develops crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic garments; and professional cleaning products. Further, it operates Gymgrossisten and Bodystore e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, Abba, Kalles, Beauvais, Den Gamle Fabrik, Spilva, Vitana, MTR, and Eastern brands; confectionery and snacks under the KiMs, Nidar, Stratos, Göteborgs Kex, Sætre, OLW, Panda, Laima, Selga, Taffel, Adazu, and Kalev brands; health and sports nutrition under Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under Odense, Mors Hjemmebakte, KronJäst, Bakkedal and NATURLI' brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ORKLA has a trailing twelve months EPS of kr4.37.

PE Ratio

ORKLA has a trailing twelve months price to earnings ratio of 15.98. Meaning, the purchaser of the share is investing kr15.98 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.77%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 12.1% and a negative 14.3%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ORKLA’s EBITDA is 33.43.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 58.39B for the twelve trailing months.

Leave a Reply

Your email address will not be published. Required fields are marked *